| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |